CBUS

Cibus, Inc.

$1.15

-0.43%
SectorHealthcareIndustryBiotechnologyCountryUnited States

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Source: Yahoo Finance
AI summary

Price & performance

1M-9.6%
3M-24.2%
YTD-25.0%
1Y-9.0%
52-week range—
Beta2.05
Full chart and returns against a benchmark

Q-Score

27/ 100

Quality against peers; 50 is the peer median.

Growth32
Risk36
Performance30
Valuation23
Profitability37
Leverage30
Sentiment35
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$3.6M-14.6%
Net income-$127.1M
Net margin—
Historical fundamentals

Red flags in filings

1active red flag
Going-concern doubtMar 17, 2026
Filings, findings and the timeline

Revenue exposure

Largest customer77%
Regions, segments, customers and suppliers

Valuation

CBUSIndustryP/E—89.69P/S20.1311.88EV/EBITDA—67.10P/B5.916.22PEG—4.02
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report, after the close
EPS estimate$-0.17
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate